Showing results (31-40 of 61) with videos related to
Sort By:
Pageof 7
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 1, 1996
Characterization of different soluble TNF receptor (TNFR80) derivatives: positive influence of the intracellular domain on receptor/ligand interaction and TNF neutralization capacityD Moosmayer, H Wajant, E Gerlach, et al.Acta Crystallographica. Section D, Biological Crystallography|July 1, 1996
Crystallographic studies and preliminary X-ray investigation of (S)-p-hydroxy-mandelonitrile lyase from Sorghum bicolor (L.)H Lauble, S Knödler, H Schindelin, et al.Mechanisms of Development|December 19, 2000
Dynamic expression of Drosophila TRAF1 during embryogenesis and larval developmentA Preiss, B Johannes, A C Nagel, et al.Cell Death & Disease|November 16, 2013
CD40-directed scFv-TRAIL fusion proteins induce CD40-restricted tumor cell death and activate dendritic cellsM El-Mesery, J Trebing, V Schäfer, et al.Oncogene|April 21, 2001
p53 upregulates cFLIP, inhibits transcription of NF-kappaB-regulated genes and induces caspase-8-independent cell death in DLD-1 cellsT Bartke, D Siegmund, N Peters, et al.Cell Death and Differentiation|October 21, 2006
Activation of CD95L fusion protein prodrugs by tumor-associated proteasesI Watermann, J Gerspach, M Lehne, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1997
Enhancement of TNF receptor p60-mediated cytotoxicity by TNF receptor p80: requirement of the TNF receptor-associated factor-2 binding siteT Weiss, M Grell, B Hessabi, et al.Cell Death & Disease|February 1, 2014
CD70-restricted specific activation of TRAILR1 or TRAILR2 using scFv-targeted TRAIL mutantsJ Trebing, M El-Mesery, V Schäfer, et al.European Journal of Biochemistry|November 3, 1998
Protein kinase Cmu downregulation of tumor-necrosis-factor-induced apoptosis correlates with enhanced expression of nuclear-factor-kappaB-dependent protective genesF J Johannes, J Horn, G Link, et al.The Journal of Biological Chemistry|November 26, 1998
TRAIL/Apo2L activates c-Jun NH2-terminal kinase (JNK) via caspase-dependent and caspase-independent pathwaysF Mühlenbeck, E Haas, R Schwenzer, et al.Pageof 7